This month, 33 care pathways have been updated with the latest evidence.
Ten pathways have received updates in line with the new NICE cancer recognition and referral guideline, Bladder cancer, Chronic kidney disease, Erectile dysfunction, Haematuria, Kidney cancer, Lower urinary tract infection (UTI) in females, Lower urinary tract infection (UTI) in males, Male lower urinary tract symptoms, Prostate cancer and Prostatitis.
The ‘Postnatal care’ pathway has been updated to reflect new NICE guidance on primary and secondary postnatal care, including new recommendations on co-sleeping and sudden infant death syndrome.
The ‘Bipolar disorder’ pathway can been updated to incorporate new NICE guidance on the assessment and management of bipolar disorder in adults, including new recommendations on psychological and pharmacological therapies, and shared monitoring of patients with bipolar disorder in both primary and secondary care.
The ‘Gastro-oesophageal reflux disease (GORD) in children and adolescents’ pathway has been updated following the release of a new guideline from the National Institute of Health and Care Excellence (NICE) on the management of gastro-oesophageal reflux disease in children and young people. It includes new recommendations on the management in primary and secondary care including referral criteria, red flag signs and pharmacological management.
The ‘Antenatal care’ pathway has received an accreditation from the Royal College of Obstetricians and Gynaecologists (RCOG).
The full list of pathways receiving an update is:
- Alcohol dependence, withdrawal, and liver disease
- Antenatal care
- Bladder cancer
- Bipolar disorder
- Brain tumour
- Chronic kidney disease
- Chronic obstructive pulmonary disease (COPD)
- Colorectal cancer
- Community-acquired pneumonia
- Crystal arthropathy
- Depression in children and adolescents
- Epilepsy in adults
- Epilepsy in children and adolescents
- Erectile dysfunction
- Gastro-oesophageal reflux disease (GORD) in children and adolescents
- Headache in adults
- Irritable bowel syndrome (IBS)
- Kidney cancer
- Lower urinary tract infection (UTI) in females
- Lower urinary tract infection (UTI) in males
- Male lower urinary tract symptoms
- Methicillin-resistant Staphylococcus aureus (MRSA)
- Multiple sclerosis
- Postnatal care
- Prostate cancer
- Refusal of treatment
- Schizophrenia and psychosis
- Substance misuse
- Venous thromboembolism (VTE) risk assessment and prophylaxis
Changes in the information landscape can be identified by different sources, including regular searches for national clinical guidelines, recently published quality-appraised secondary literature, and user feedback. The impact of new information is assessed to determine a timeframe for updating the care map. Practice-based knowledge from clinical experts is then added where appropriate.
Download the report below for a brief summary of changes for all care maps updated in this publication.